Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts.

Maven Clinic, a virtual clinic for women’s and family health, has secured $125 million in Series F funding, the company announced Tuesday. New York City-based Maven Clinic offers support for ...

With pressure building on Congress to solidify telehealth payment flexibilities set to expire at the end of the year, we must ensure legislators weigh the ability of virtual health care services ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a ...

The healthcare industry is on the cusp of a transformation similar to that witnessed by the banking industry 15 to 20 years ago. Like healthcare, banking is a very personal yet highly regulated ...

AI has been the talk of the healthcare industry, garnering excitement for its potential to improve patient care, as well as concern for the need to implement it ethically. But does the technology ...

HLTH, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, spotlights individuals across the healthcare ecosystem from high-powered executives such as Fred Abnousi, the head of ...

Bipartisan Congressional scrutiny has shone a harsh spotlight on the many tactics used by pharmacy benefit managers (PBMs) and Big Pharma that contribute to the sky high costs of prescription ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Bayo Curry ...

When proteins cause disease, the body has ways to tackle them. An emerging class of therapies that leverage a cell’s built-in systems to eliminate rogue proteins has already reached the clinic ...

Advancements in surgical technology and therapeutics have improved outcomes for many cancer patients, resulting in 18 million survivors (and growing). New and more efficacious cancer drugs are ...

Hospitals’ operational margins have shrunk dramatically this year. Now more than ever, hospitals need to ensure they’re getting the most out of their investments in technology. Clear ...